Information about Pharma Invest
My details
*
*
*

Pharma Invest (SA)

BE 0449.788.505

Chaussée de Waterloo 799, 1180 Uccle

Company information

Status
Active

Enterprise number

BE0449.788.505

VAT liability
No
Established
31-03-1993
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pharma Invest

2024 2023 2022 2021
Profit/Loss € 65,322 3021 % € 2,093 -96 % € 50,113 -3 % € 51,638
Equity € 704,211 10 % € 638,888 0 % € 636,795 9 % € 586,682
Gross margin € 102,851 44 % € 71,398 -4 % € 74,160 -3 % € 76,354

Publications from Pharma Invest

Date Publication
07-10-2025 Resignations, Appointments (FR)
09-10-2020 Resignations, Appointments (FR)
17-10-2019 Resignations, Appointments (FR)
25-07-2013 Resignations, Appointments (FR)
18-01-2008 Resignations, Appointments (FR)

Frequently asked questions

What is the enterprise number of Pharma Invest?
The enterprise number of Pharma Invest is BE 0449.788.505.
Wat is the PEPPOL ID of Pharma Invest?
There is no information available about the PEPPOL ID of Pharma Invest or the company is not yet registered on the PEPPOL network.
When was Pharma Invest founded?
Pharma Invest was founded on 31-03-1993.
What is the address of Pharma Invest?
The current registered office of Pharma Invest is located at Chaussée de Waterloo 799, 1180 Uccle.
When was the last time Pharma Invest filed their annual financial statements?
The most recent financial statements of Pharma Invest were filed on 02-08-2025.
How many employees does Pharma Invest have?
There are currently no employees working at Pharma Invest or no workforce information is available.
What is the annual turnover of Pharma Invest?
At the time of its most recent financial statements, Pharma Invest did not publish any turnover figures. Pharma Invest reported a gross margin of €102,851.32.

Sources